AU2017313823A1 - Methods of treating developmental disorders with biguanides - Google Patents
Methods of treating developmental disorders with biguanides Download PDFInfo
- Publication number
- AU2017313823A1 AU2017313823A1 AU2017313823A AU2017313823A AU2017313823A1 AU 2017313823 A1 AU2017313823 A1 AU 2017313823A1 AU 2017313823 A AU2017313823 A AU 2017313823A AU 2017313823 A AU2017313823 A AU 2017313823A AU 2017313823 A1 AU2017313823 A1 AU 2017313823A1
- Authority
- AU
- Australia
- Prior art keywords
- syndrome
- metformin
- patient
- disorder
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
- C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662376488P | 2016-08-18 | 2016-08-18 | |
| US62/376,488 | 2016-08-18 | ||
| PCT/US2017/047505 WO2018035408A1 (en) | 2016-08-18 | 2017-08-18 | Methods of treating developmental disorders with biguanides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2017313823A1 true AU2017313823A1 (en) | 2019-02-28 |
Family
ID=61190982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2017313823A Abandoned AU2017313823A1 (en) | 2016-08-18 | 2017-08-18 | Methods of treating developmental disorders with biguanides |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10123979B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3484452A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2019524834A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20190039974A (cg-RX-API-DMAC7.html) |
| CN (1) | CN109715144A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017313823A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3033967A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2019001937A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018035408A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10295547B2 (en) | 2013-03-14 | 2019-05-21 | University Of Florida Research Foundation, Incorporated | Use and treatment of di-amino acid repeat-containing proteins associated with ALS |
| US10509045B2 (en) | 2015-05-29 | 2019-12-17 | University Of Florida Research Foundation, Incorporated | Methods for diagnosing Huntington's disease |
| US10940161B2 (en) | 2016-04-04 | 2021-03-09 | University Of Florida Research Foundation, Incorporated | Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation |
| WO2018035408A1 (en) | 2016-08-18 | 2018-02-22 | Ovid Therapeutics Inc. | Methods of treating developmental disorders with biguanides |
| EP3612190A4 (en) * | 2017-04-17 | 2021-01-20 | University of Florida Research Foundation, Incorporated | REGULATION OF RAN TRANSLATION THROUGH PKR AND EIF2A-P WAYS |
| EP3688020A4 (en) | 2017-09-25 | 2021-07-14 | University of Florida Research Foundation, Incorporated | IMMUNOASSAYS FOR DETECTION OF RAN PROTEINS |
| AU2018342105B2 (en) * | 2017-09-26 | 2023-11-16 | University Of Florida Research Foundation, Incorporated | Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders |
| GB201912760D0 (en) * | 2019-09-05 | 2019-10-23 | Healx Ltd | Treatment |
| AU2020348916B2 (en) | 2019-09-20 | 2025-12-18 | University Of Florida Research Foundation, Incorporated | Detection of antibodies against RAN proteins from serum and tissue lysates |
| WO2021072187A2 (en) | 2019-10-10 | 2021-04-15 | University Of Florida Research Foundation, Incorporated | Ran proteins as biomarkers in cag/ctg expansion disorders |
| GB202008699D0 (en) * | 2020-06-09 | 2020-07-22 | Healx Ltd | Treatment |
| CN113318111B (zh) * | 2021-06-21 | 2026-02-03 | 浙江大学 | Nav1.1激动剂在制备治疗自闭症的药物中的应用 |
| US20250041247A1 (en) * | 2021-12-01 | 2025-02-06 | University Of Florida Research Foundation, Incorporated | Small molecule inhibitors of repeat associated non-aug (ran) translation and combination therapies |
| US20230186023A1 (en) * | 2021-12-13 | 2023-06-15 | International Business Machines Corporation | Automatically assign term to text documents |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6099859A (en) * | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
| AU2003261298A1 (en) * | 2002-08-02 | 2004-02-23 | Penwest Pharmaceuticals Company | Sustained release formulations of metformin |
| US20060147947A1 (en) * | 2002-12-04 | 2006-07-06 | Javier Apfeld | AMPK pathway components |
| US8252321B2 (en) * | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| WO2008097861A2 (en) * | 2007-02-02 | 2008-08-14 | Braincells, Inc. | MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS |
| CN102058888B (zh) * | 2009-05-01 | 2014-06-11 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种治疗能量代谢异常的药物组合物和其应用 |
| EP2653158B1 (en) * | 2010-12-13 | 2017-07-05 | Fukuoka University | Therapeutic agent for blood-brain barrier disruption syndrome |
| EP3013371A4 (en) * | 2013-06-26 | 2017-04-26 | Rett Syndrome Research Trust | Rett syndrome and treatments therefore |
| WO2018035408A1 (en) | 2016-08-18 | 2018-02-22 | Ovid Therapeutics Inc. | Methods of treating developmental disorders with biguanides |
-
2017
- 2017-08-18 WO PCT/US2017/047505 patent/WO2018035408A1/en not_active Ceased
- 2017-08-18 CN CN201780057960.3A patent/CN109715144A/zh active Pending
- 2017-08-18 US US15/680,417 patent/US10123979B2/en active Active
- 2017-08-18 EP EP17842173.1A patent/EP3484452A4/en not_active Withdrawn
- 2017-08-18 AU AU2017313823A patent/AU2017313823A1/en not_active Abandoned
- 2017-08-18 MX MX2019001937A patent/MX2019001937A/es unknown
- 2017-08-18 CA CA3033967A patent/CA3033967A1/en not_active Abandoned
- 2017-08-18 KR KR1020197006647A patent/KR20190039974A/ko not_active Ceased
- 2017-08-18 JP JP2019508879A patent/JP2019524834A/ja active Pending
-
2018
- 2018-10-11 US US16/157,653 patent/US10426746B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN109715144A (zh) | 2019-05-03 |
| US10123979B2 (en) | 2018-11-13 |
| US20180050001A1 (en) | 2018-02-22 |
| JP2019524834A (ja) | 2019-09-05 |
| US20190046480A1 (en) | 2019-02-14 |
| EP3484452A4 (en) | 2020-04-01 |
| KR20190039974A (ko) | 2019-04-16 |
| WO2018035408A1 (en) | 2018-02-22 |
| MX2019001937A (es) | 2019-10-02 |
| CA3033967A1 (en) | 2018-02-22 |
| EP3484452A1 (en) | 2019-05-22 |
| US10426746B2 (en) | 2019-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10426746B2 (en) | Methods of treating developmental disorders with biguanides | |
| US12465597B2 (en) | Methods of treating developmental disorders with gaboxadol | |
| AU2021257943A1 (en) | Methods of treating developmental disorders and/or seizure disorders with flupirtine and/or gaboxadol | |
| HK40097170A (zh) | 用加波沙朵治疗发育障碍的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |